Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Kezar Life Sciences Inc. (KZR)

4.77   -0.48 (-9.14%) 05-29 15:59
Open: 5.18 Pre. Close: 5.25
High: 5.29 Low: 4.75
Volume: 149,799 Market Cap: 182M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.518 - 5.546 5.546 - 5.569
Low: 5 - 5.027 5.027 - 5.05
Close: 5.208 - 5.253 5.253 - 5.29

Technical analysis

as of: 2020-05-29 3:27:58 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 6.70     One year: 7.79
Support: Support1: 4.23    Support2: 3.52
Resistance: Resistance1: 5.74    Resistance2: 6.67
Pivot: 5.36
Moving Average: MA(5): 5.23     MA(20): 5.32
MA(100): 4.39     MA(250): 4.47
MACD: MACD(12,26): 0.10     Signal(9): 0.18
Stochastic oscillator: %K(14,3): 20.75     %D(3): 28.31
RSI: RSI(14): 44.90
52-week: High: 9.95  Low: 2.18  Change(%): -48.3
Average Vol(K): 3-Month: 21649  10-Days: 16483

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
KZR has closed above bottom band by 14.8%. Bollinger Bands are 19.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 28 May 2020
Kezar Life Sciences to Participate in Fireside Chat During the Jefferies Virtual Healthcare Conference - GlobeNewswire

Thu, 07 May 2020
Kezar Life Sciences Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire

Mon, 11 May 2020
Why Earnings Season Could Be Great for Kezar Life Sciences (KZR) - Yahoo Finance

Mon, 11 May 2020
H.C. Wainwright Sticks to Their Buy Rating for Kezar Life Sciences Inc - Yahoo Finance

Mon, 11 May 2020
We're Not Very Worried About Kezar Life Sciences's (NASDAQ:KZR) Cash Burn Rate - Yahoo Finance

Wed, 06 Nov 2019
Kezar Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38
Shares Float (M) 25
% Held by Insiders 34.18
% Held by Institutions 35.56
Shares Short (K) 971
Shares Short P. Month (K) 992

Stock Financials

EPS -1.660
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 3.210
Profit Margin
Operating Margin
Return on Assets (ttm) -19.9
Return on Equity (ttm) -33.3
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.999
Qtrly Earnings Growth
Operating Cash Flow (M) -31
Levered Free Cash Flow (M) -18

Stock Valuations

PE Ratio -2.89
PEG Ratio
Price to Book value 1.50
Price to Sales
Price to Cash Flow -5.82

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.